Archivio Categoria: series B

Boosted Scoops Up $60M Series B Round

Boosted 915 Linda Vista AveMountain View, CA 94043650-933-5151boostedboards.com Key contact Name Title Jeff Russakow CEO MOUNTAIN VIEW, CA, Boosted, maker of an electric skateboard and provider of last-mile electric vehicles, announced it has raised $60 million in a Series B round of funding. According to Silicon Valley Business Journal, Electric skateboard startup Boosted said that […]

Fair Nabs $385M Series B

Fair 1540 2nd Street 2nd FlSanta Monica, CA 90401833-387-6677http://www.fair.com/ Key contact Name Title Scott Painter Founder & CEO SANTA MONICA, CA, After scaling nationwide in 2018, car-as-a-service provider Fair today announced it has raised $385 million in a Series B financing led by SoftBank. The investment is anticipated to enable the company to scale its […]

Securly Raises $16M Series B

Securly 111 N Market StSan Jose, CA 951131-855-SECURLYhttps://www.securly.com/ Key contact Name Title Vinay Mahadik Co-Founder and CEO SAN JOSE, CA, Securly has raised $16 million of Series B financing led by Defy Partners. Securly, a startup focused on the mission of keeping kids safe online – in schools, at home, and anywhere off campus – […]

Import.io Lands $15.5M Series B Financing

Import.io San Francisco, CAhttps://www.import.io/ Key contact Name Title David White CEO and Co-Founder LOS GATOS, CA, Import.io today announced it has closed a $15.5 million Series B funding round. Import.io, the leading web data integration solution provider, today announced it has closed a $15.5 million Series B funding round to accelerate global growth and expand […]

RightHand Robotics Snags $23M Series B

RightHand Robotics 28 Dane St.Somerville, MA 02143617-520-4199https://www.righthandrobotics.com/ Key contact Name Title Lael Odhner Co-Founder BOSTON, MA, RightHand Robotics, a leader in providing integrated robotic piece-picking solutions, announced today that it has secured $23 million in a Series B funding round. The round was led by Menlo Ventures, an active investor in the robotics sector. GV […]

Tridiuum Nabs $9.5M Series B

Tridiuum 1650 Arch St, Suite 2000Philadelphia, PA 19103484-588-6700https://tridiuum.com/ Key contact Name Title Mark Redlus CEO PHILADELPHIA, PA, Digital health company Tridiuum has secured $9.5 million in Series B financing. Tridiuum has secured $9.5 million in Series B financing, which includes equity capital from lead investor Sopris Capital and strategic co-investor Fresenius Medical Care Ventures, and […]

Avanan Raises $25M in Series B

Avanan 137 Varick St., 2nd FloorNew York, NY 10013http://www.avanan.com/ Key contact Name Title Gil Friedrich CEO NEW YORK, NY, Avanan has raised $25 million in Series B funding. Avanan, an enterprise security provider for SaaS-based email and collaboration platforms, announced today that it has raised $25 million in Series B funding from existing investors StageOne […]

Mission Bio Receives $30M Series B

Mission Bio 953 Indiana St.San Francisco, CA 94107415-854-0058http://missionbio.com/ Key contact Name Title Charlie Silver CEO SOUTH SAN FRANCISCO, CA, Mission Bio, the pioneer in single-cell DNA analysis and precision genomics, today announced it raised $30 million in Series B funding. The funding comes from Agilent Technologies (NYSE: A), Cota Capital, LAM Capital, and Mayfield, bringing […]

Tigera Raises $30M Series B

Tigera 58 Maiden Lane, 5th FloorSan Francisco, CA 94108415-612-9546https://www.tigera.io/ Key contact Name Title Ratan Tipirneni CEO SAN FRANCISCO, CA, Tigera announced the closing of its Series B funding round of $30 million led by Insight Venture Partners. Tigera, an enterprise software company providing security and compliance solutions for Kubernetes platforms, today announced the closing of […]

Akero Therapeutics Inks $70M in Series B

Akero Therapeutics 400 Technology Square, 10th FloorCambridge, MA 02139http://akerotx.com/ Key contact Name Title Jonathan Young CEO SAN FRANCISCO, CA, Biotechnology company has closed $70 million in new Series B financing. Akero Therapeutics, Inc., a biotechnology company developing transformational treatments for non-alcohol steatohepatitis (NASH) and other serious metabolic diseases, today announced the company has closed $70 […]